Moszczuk Barbara, Kiryluk Krzysztof, Pączek Leszek, Mucha Krzysztof
Department of Immunology, Transplantology and Internal Diseases, Medical University of Warsaw, 02-006 Warsaw, Poland.
Department of Clinical Immunology, Medical University of Warsaw, 02-006 Warsaw, Poland.
J Clin Med. 2021 Mar 14;10(6):1205. doi: 10.3390/jcm10061205.
Membranous nephropathy is a glomerulopathy that causes nephrotic syndrome and, in at least a third of cases, lasting end-stage kidney disease (ESKD). It is also a rare case of revolutionary changes in our understanding of the disease, that translates from scientific findings to real diagnosis and treatment recommendations in less than ten years. In this review we present: (1) a short history and traditional approach to patients with membranous nephropathy, (2) current recommendations and treatment options that have emerged in recent years, (3) findings of new studies, with a particular focus on serological/immunological methods, genomic and proteomic studies, still requiring validation. With further development in this field, membranous nephropathy may become one of the first nephrological conditions that apply a truly personalized approach with the omission of invasive measures such as kidney biopsy.
膜性肾病是一种导致肾病综合征的肾小球疾病,至少三分之一的病例会发展为终末期肾病(ESKD)。它也是我们对该疾病的认识发生革命性变化的罕见案例,在不到十年的时间里,从科学发现转化为实际的诊断和治疗建议。在这篇综述中,我们介绍:(1)膜性肾病患者的简短病史和传统治疗方法,(2)近年来出现的当前建议和治疗选择,(3)新研究的结果,特别关注血清学/免疫学方法、基因组和蛋白质组学研究,这些研究仍需验证。随着该领域的进一步发展,膜性肾病可能成为最早采用真正个性化方法且无需进行肾活检等侵入性措施的肾脏疾病之一。